ArticleScientific reports2024

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes.

Alexandra Rabin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.